Virtu Financial LLC Vaccinex, Inc. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$0.39 - $0.65 $40,520 - $67,533	103,898 New	103,898 $42,000
Q3 2022 Nov 07, 2022	SELL	$0.48 - $109.22 $260 - $59,197	-542 Reduced 4.97%	10,370 $5,000
Q2 2022 Aug 09, 2022	BUY	$1.05 - $1.39 $11,457 - $15,167	10,912 New	10,912 $12,000
Q3 2021 Nov 12, 2021	SELL	$2.11 - $2.81 $80,234 - $106,853	-38,026 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$2.01 - $3.0 $38,941 - $58,122	19,374 Added 103.87%	38,026 $106,000
Q1 2021 May 19, 2021	BUY	$2.09 - $5.11 $38,982 - $95,311	18,652 New	18,652 $56,000
Q4 2020 Feb 24, 2021	SELL	$1.66 - $2.35 $43,573 - $61,685	-26,249 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$1.75 - $8.19 $45,935 - $214,979	26,249 New	26,249 $47,000

426K

Ticker VCNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,664,100
Market Cap $49.1M
Description
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.